Note that some links may require subscriptions.
A patient in Massachusetts grabbed his nurse by the neck Monday night and cut her near the carotid artery with his pocket knife as she tried to adjust his oxygen tube, prosecutors said. (NBC Boston)
Rochelle Walensky, MD, MPH, faced a House COVID panel on Tuesday for what may be the last time as CDC director; she leaves the agency later this month. (The Hill)
Gov. Greg Abbott (R) signed a patient safety bill that gives the Texas Medical Board tools to better protect patients from potentially dangerous doctors. (KXAN)
In Arkansas, 140,000 people have lost Medicaid coverage since April: here's why. (Politico)
Side effects of obesity drugs like semaglutide (Wegovy) may include shame. (New York Times)
Less than one in four residential addiction treatment facilities for adolescents offered buprenorphine for opioid use disorder, a "secret shopper" study showed. (JAMA)
Many suicide hotlines send sensitive data on visitors to Facebook. (The Markup)
Can storytelling help make better doctors? (The Guardian)
At least 1.7 million Americans rely on healthcare sharing plans in which people agree to pay one another's medical bills -- a number higher than previously thought. (CBS News)
Italy's prime minister pledged to pass a "right to be forgotten" law to shield cancer survivors from discrimination by banks or insurance companies. (Reuters)
Alcohol may lower the risk of major adverse cardiovascular events by reducing stress-related neural network activity. (Journal of the American College of Cardiology)
Lesbian, gay, and bisexual adults were more likely than straight adults to use substances, experience mental health issues including major depressive episodes, and have serious thoughts of suicide, new data from the Substance Abuse and Mental Health Services Administration showed.
Widely used algorithms had limited clinical utility in predicting 10-year dementia risk in patients. (JAMA Network Open)
Two commonly used forms of injectable penicillin -- Bicillin L-A and Bicillin C-R -- are in short supply and may run out before the end of year, Pfizer warned. (The Hill)
FDA passed along tips to reduce formaldehyde release on certain GE HealthCare neonatal incubators.
Odevixibat (Bylvay), a non-systemic ileal bile acid transport inhibitor, gained a new indication to treat cholestatic pruritus due to Alagille syndrome, drugmaker Ipsen said.
Adverse childhood experiences appeared to accelerate epigenetic age in midlife. (JAMA Network Open)